Upcoming events
Coming soon
Past events
EuroPCR 2024 – Paris, May 14th – 17th
Sponsored symposium
The turning point in hypertension care: Symplicity™ Spyral renal denervation in practice.
Moderator: Flavio Ribichini
Spokesperson: Rasha Al Lamee
Speakers: Valérie Duchatelle, Roland Schmieder, Andrew Sharp
Watch the replay
Physician education sites
Medscape education (CME credits available)
Medscape education
Clinical advances in interventional innovations for blood pressure control.
Medscape’s education platform helps physicians learn about recent data with innovative interventional technology that can help patients achieve blood pressure control as an alternative to, or in addition to, typical treatment plans that include anti-hypertensive medications and lifestyle modifcations. CME credits available.
Conference videos
Clinical data videos
PCR23: Efficacy, safety and durability of RF RDN
Can renal denervation reduce cardiovascular events?
Renal denervation safety, durability and high-risk patients
Totality of evidence for RF renal denervation
Real-world experience with renal denervation
The science behind RF renal denervation safety and durability: SORT overview 2022
SPYRAL HTN-ON MED 3 year results
SPYRAL HTN-ON MED trial results
Select the right patients
See which types of patients could beneft from the Symplicity blood pressure procedure.
Extensive clinical evidence
The Symplicity blood pressure procedure is supported by multiple clinical trials and a real-world patient registry.1-4
Transforming hypertension treatment
The Symplicity blood pressure procedure is changing how patients with hypertension can reduce their blood pressure.
1
Mahfoud F, Kandzari DE, Kario K, et al. Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial. The Lancet. 2022;399:1401-1410.
2
Mahfoud F, Mancia G, Schmieder R, et al. Three-year safety and efficacy in the Global Symplicity Registry: Impact of antihypertensive medication burden on blood pressure reduction. Presented at PCR e-course 2020.
3
Böhm M, Kario K, Kandzari DE, et al. Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial. The Lancet. 2020;395:1444-1451.
4
Kandzari DE, Böhm M, Mahfoud F, et al. Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial. The Lancet. 2018;391(10137):2346.